Edition:
United States

Ovid Therapeutics Inc (OVID.OQ)

OVID.OQ on NASDAQ Stock Exchange Global Select Market

10.14USD
19 Apr 2018
Change (% chg)

$0.42 (+4.32%)
Prev Close
$9.72
Open
$9.70
Day's High
$10.18
Day's Low
$9.70
Volume
8,824
Avg. Vol
28,621
52-wk High
$15.70
52-wk Low
$5.28

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17 0.00 -0.057
Sep '17 0.00 -0.380
Jun '17 0.00 -0.566
Mar '17 0.00 -1.392
FY 2016 Dec '16 0.00 -0.307
Sep '16 0.00 -0.235
Jun '16 0.00 -0.219
Mar '16 0.00 -0.150
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-18 4 0.00 0.00 0.00 --
Quarter Ending Sep-18 4 0.00 0.00 0.00 --
Year Ending Dec-18 4 0.00 0.00 0.00 --
Year Ending Dec-19 3 0.00 0.00 0.00 --
Earnings (per share)
Quarter Ending Jun-18 5 -0.54 -0.44 -0.62 --
Quarter Ending Sep-18 5 -0.55 -0.45 -0.65 --
Year Ending Dec-18 5 -2.15 -1.80 -2.42 --
Year Ending Dec-19 4 -2.69 -2.48 -2.83 --
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.91 33.50
P/E High - Last 5 Yrs. -- 289.20 46.07
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta -- 0.75 0.80
Price to Sales (TTM) -- 139.09 7.25
Price to Book (MRQ) 2.87 20.64 5.09
Price to Tangible Book (MRQ) 2.87 25.50 6.62
Price to Cash Flow (TTM) -- 130.26 25.50
% Owned Institutions 32.77 11.26 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.05 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 81.71 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 96.34 11.19
Sales - 5 Yr. Growth Rate -- 34.26 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago 81.32 -64.57 22.73
EPS (TTM) vs TTM 1 Yr. Ago -296.87 -- --
EPS - 5 Yr. Growth Rate -- 48.47 10.28
Capital Spending - 5 Yr. Growth Rate -- 45.82 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.53
Current Ratio (MRQ) 14.71 6.04 3.61
LT Debt to Equity (MRQ) 0.00 23.33 11.39
Total Debt to Equity (MRQ) 0.00 25.72 14.02
Interest Coverage (TTM) -- -190.60 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 35.01 54.05
Gross Margin - 5 Yr. Avg. -- 55.51 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -150.51 15.90
Operating Margin (TTM) -- -562.45 4.09
Operating Margin - 5 Yr. Avg. -- -162.33 11.23
Pre-Tax Margin (TTM) -- -534.74 4.81
Pre-Tax Margin - 5 Yr. Avg. -- -168.92 11.54
Net Profit Margin (TTM) -- -524.03 1.42
Net Profit Margin - 5 Yr. Avg. -- -168.92 7.87
Effective Tax Rate (TTM) -- -0.15 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.29 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 24,331,705 813,295,447
Net Income/Employee (TTM) -1,285,152 1,121,504 95,590,786
Receivable Turnover (TTM) -- 6.53 5.56
Inventory Turnover (TTM) -- 2.32 3.44
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -77.57 -0.74 10.51
Return on Assets - 5 Yr. Avg. -- 0.80 11.54
Return on Investment (TTM) -83.27 -0.75 13.17
Return on Investment - 5 Yr. Avg. -- 4.16 14.94
Return on Equity (TTM) -83.28 -2.86 14.98
Return on Equity - 5 Yr. Avg. -- -0.19 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -213.55 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ovid Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 23.82 23.97 93 23
13 Week 6.23 9.91 68 82
26 Week 18.10 11.68 71 90
52 Week -- -- -- 80
YTD -1.52 -2.79 48 91
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 32.83%
# of Holders: 73
Total Shares Held: 8,082,360
3 Mo. Net Change: 24,991
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 7
# Reduced Positions: 2
# Net Buyers: 5
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.